CB

Carl Brooks

GL Glaxosmithkline Intellectual Property Development Limited: 1 patents #33 of 146Top 25%
GL Glaxosmithkline Intellectual Property (No. 4) Limited: 1 patents #9 of 32Top 30%
📍 King of Prussia, PA: #8 of 70 inventorsTop 15%
🗺 Pennsylvania: #1,116 of 7,685 inventorsTop 15%
Overall (2021): #175,283 of 548,734Top 35%
2
Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11028099 NRF2 activators Jay M. Matthews 2021-06-08
10968209 TRPV4 antagonist Patrick Stoy, Guosen Ye 2021-04-06